<DOC>
	<DOCNO>NCT02611869</DOCNO>
	<brief_summary>120 consecutive patient paroxysmal AF , slat PV isolation , randomly assign RF cryoballoon ablation ( 1:2 allocation scheme ) . Real-time 3D echocardiography ( RT3DE ) perform ablation procedure 1 month post-ablation . The RT3DE datasets store digitally quantitative analysis perform off-line core echo laboratory . Quantification leave atrial volume perform left atrial functional quantification perform calculate follow index : Left atrial ejection fraction , Active atrial empty fraction , Passive atrial empty fraction , Atrial expansion index . All patient hospitalize 48 hour post-ablation . Blood sample obtain 12-hour interval measure troponin T high-sensitivity assay , well biochemical parameter .</brief_summary>
	<brief_title>Effect Cryoballoon RF Ablation Left Atrial Function</brief_title>
	<detailed_description>The study involve 2 study intervention , cryoballoon RF ablation , patient randomly assign ( 2:1 allocation scheme ) . Randomization perform centrally use random number generator - follow short script use R language generate random sequence 2:1 probability assignment cryoballoon versus RF . Each patient 's randomization know operator ablation procedure ( course investigator attend procedure record procedural parameter , complication , outcome etc. ) . All personnel involve patient follow-up echo data analysis blind patient randomization ( patient record accompany randomization number correspond masked randomization list keep digital form coordinating center , unlocked completion last patient 's follow-up ) . The Ablation Procedure Data Sheet file separately CRF document maintain blind . 1 . RF ablation Antral PV isolation perform patient randomize RF ablation , without additional ablation extrapulmonary site , exception individual document typical atrial flutter . An irrigated radiofrequency ablation catheter use perform ablation , aid electroanatomical mapping ( Carto 3 , Biosense Webster ) , follow single transeptal puncture . Pulmonary vein potential record circular mapping catheter ( Lasso® NAV eco , Biosense Webster ) , follow antral ablation ( default strategy create two ablation line , around two ipsilateral pulmonary vein , unless leave atrial anatomy dictate another approach ) . The endpoint ablation procedure entrance exit block pulmonary vein . A waiting time 20-30 minute observe initial pulmonary vein isolation ablation perform case reconduction vein atrium . Patients history document sustained typical atrial flutter ablation procedure additionally undergo cavotricuspid isthmus ablation . Use additional modality , include intracardiac ultrasound integration compute tomography magnetic resonance image anatomical data leave atrium , leave discretion operator . Repeat ablation allow 3-month follow-up study . 2 . Cryoablation A single big cryoballoon approach , use 28-mm cryoballoon ( Arctic Front Advance™ Cardiac CryoAblation Catheter , Medtronic , Minneapolis , MN ) employ . The cryoballoon catheter introduce left atrium , follow single transeptal puncture , 12F FlexCath steerable sheath ( Medtronic ) , constantly flush heparinized saline . A circular mapping catheter ( Achieve , Medtronic ) advance cryoballoon PV orifice position proximally possible inside vessel record PV potential baseline monitor isolation procedure real time . The cryoballoon inflate advanced ostium PV . The quality vascular occlusion ascertain injection dilute contrast material PV . Once best occlusion obtain , cryothermal energy apply 240 second , recommend manufacturer . An additional application energy systematically deliver PV isolation . Before ablation right-sided PVs , quadripolar electrode catheter position superior vena cava constantly pace right phrenic nerve 2-sec cycle length freeze . In case cessation weaken diaphragmatic contraction , freeze immediately discontinue . iv ) Real-time 3D echocardiographic evaluation leave atrial dimension function Real-time 3D echocardiography ( RT3DE ) perform ablation procedure 1 month post-ablation , iE33 machine ( Philips Medical Systems , Bothell , Washington ) equip X3 , fully sample matrix transducer . Apical full-volume data set obtain end-expiratory apnea within 1 breath hold . The RT3DE datasets store digitally quantitative analysis perform off-line core echo laboratory ( different site recruiting center ) personnel blind patient 's treatment allocation . Quantification leave atrial volume perform use semiautomated contour trace algorithm , mark 5 atrial reference point : 4 anterior , inferior , lateral , septal part atrial dome 1 level mitral annulus . Volumes measure three time point cardiac cycle : ( ) LAmax end-systole , mitral valve opening , ( b ) LAmin end-diastole , mitral valve closure ; ( c ) LApreA obtain time P wave surface electrocardiogram . Indexing body surface area apply , recommended.11 Left atrial functional quantification perform calculate follow index : - Left atrial ejection fraction : LAEF = [ ( LAmax - LAmin ) /LAmax ] * 100 % - Active atrial empty fraction : LAactive = [ ( LApreA - LAmin ) /LApreA ] * 100 % - Passive atrial empty fraction : LApassive = [ ( LAmax - LApreA ) /LAmax ] * 100 % - Atrial expansion index : LAreservoir = [ ( LAmax - LAmin ) /LAmin ] * 100 % . Echocardiographic evaluation also include standard 2D Doppler measurement . Measurements particular interest : leave ventricular ejection fraction ( modify Simpson 's rule ) , mitral E/e ' velocity ratio ( lateral aspect mitral annulus ) , semi-qualitative assessment mitral regurgitation ( grade 0 3 : regurgitation , mild , moderate , severe ) , right ventricular systolic pressure . v ) Other study procedure Before index procedure , run-in visit , eligibility criterion review 24-hour Holter record undertaken . All patient hospitalize 48 hour post-ablation . Blood sample obtain 12-hour interval measure troponin T high-sensitivity assay , well biochemical parameter ( blood sample centrifuge plasma aliquot keep -80oC measurement ) . Patients return 2 visit ablation procedure : 1-month visit RT3DE , symptom review , assessment potential complication , clinical electrocardiographic evaluation , 24-h Holter recording , 3-month visit symptom review , assessment potential complication , clinical electrocardiographic evaluation , 24-h Holter recording .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>At least two AF episode within last 12 month ( either selfterminating within 7 day cardioverted , medically electrically , less 48 hour ) , AF episodes symptomatic least 2 occasion within last 12 month , Failure least one class I III antiarrhythmic prevent AF paroxysm , Age 4080 year old . Previous leave atrial ablation procedure , Left atrial diameter &gt; 50 mm TTE ( parasternal long axis view ) , Known primary electrical heart disease ( e.g . Brugada syndrome ) , Presence atrial thrombus , Prosthetic valve position , Moderate/severe mitral stenosis , Severe mitral regurgitation , Active infectious disease malignancy , Moderate severe hepatic impairment ( ChildPugh class B C ) , Severe renal failure ( estimate glomerular filtration rate &lt; 20 ml/min/1.73 m2 ) , Participation different research protocol ( current within 1 year ) , Inability unwillingness adhere standard treatment provide consent .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>